Campylobacter jejuni infections and anti-GM1 antibodies in Guillain- Barre syndrome

Annals of Neurology

Volumn 40, Issue 2, 1996, Pages 181-187

  Jacobs, Bart C ^a,c   Van Doorn, Pieter A ^a   Schmitz, Paul I M ^a   Tio Gillen, Anne P ^a   Herbrink, Paul ^b   Visser, Leo H ^a   Hooijkaas, Herbert ^a   Van Der Meché, Frans G A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY DETECTION; ARTICLE; BACTERIAL INFECTION; CAMPYLOBACTER JEJUNI; CLINICAL FEATURE; CONTROLLED STUDY; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; PRIORITY JOURNAL;

EID: 0029841961     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400209     Document Type: Article

References (37)

1. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27(suppl):S21-S24
2. Van der Meché FGA, Meulstee J, Vermeulen M, Kievit A. Patterns of conduction failure in the Guillain-Barré syndrome. Brain 1988;111:405-416
3. Van der Meché FGA, van Doom PA. Guillain-Barré syndrome and chronic inflammatory demyeltnating polyneuropathy: immune mechanisms and update on current therapies. Ann Neurol 1995;37(suppl):S14-S31
4. Kaldor J, Speed BR. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br Med J 1984;288:1867-1870
5. Winer JB, Hughes RAC, Anderson MJ, et al. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 1988;51:613-618
6. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-1902
7. Walsh FS, Cronin M, Koblar S, et al. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol 1991; 34:43-51
8. Boucquey D, Sindic CJM, Lamy M, et al. Clinical and serological studies in a series of 45 patients with Guillain-Barré syndrome. J Neurol Sci 1991;104:56-63
9. Mishu B, Ilyas AA, Koski CL, et al. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med 1993;118:947-953
10. Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann Neurol 1993;34:130-135
11. Enders U, Karch H, Toyka KV, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 1993;34:136-144
12. Von Wulffen H, Hartard C, Scharein E. Seroreactiviry to Campylobacter jejuni and gangliosides in patients with Guillain-Barré syndrome. J Infect Dis 1994;170:828-833
13. Rees JH, Hughes RAC. Campylobacter jejuni and Guillain-Barré syndrome. Ann Neurol 1994;35:248-249 (Letter)
14. Visser LH, van der Meché FGA, van Doorn PA, et al. Guillain-Barré syndrome without sensory loss (acute motor neuropathy). Brain 1995;118:841-847
15. Van den Berg LH, Marrink J, De Jager AEJ, et al. Anti-GM1 antibodies in patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1992;55:8-11
16. Nobile-Orazio E, Carpo M, Meucci N, et al. Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies. J Neurol Sci 1992;109:200-206
17. Ilyas AA, Mithen FA, Dalakas MC, et al. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sei 1992;107: 111-121
18. Simone IL, Annunziata P, Maimone D, et al. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1993;114:49-55
19. Gregson NA, Koblar S, Hughes RAC. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q J Med 1993;86:111-117
20. Van der Meché FGA, Schmitz PIM, Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992;326:1123-1129
21. The Dutch Guillain-Barré Study Group. Treatment of Guillain-Barré syndrome with high-dose immunoglobulins combined with methylprednisolone: a pilot study. Ann Neurol 1994;35:749-752
22. Kleyweg RP, van der Meché FGA, Schmitz PIM. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 1991;14: 1103-1109
23. Herbrink P, van den Munckhof HAM, Bumkens M, et al. Human serum antibody response in Campylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay. Eur J Clin Microbiol Infect Dis 1988;7:388-393
24. Herbrink P, van Loon AM, Rotmans JP, et al. Interlaboratory evaluation of indirect enzyme-linked immunosorbent assay, antibody capture enzyme-linked immunosorbent assay, and immunoblotting for detection of immunoglobulin M antibodies to Toxoplasma gondii. J Clin Microbiol 1987;25:100-105
25. Jacobs BC, Endtz HPh, van der Meché FGA, et al. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann Neurol 1995;37:260-264
26. Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988;24:73-78
27. Kornberg AJ, Pestronk A, Bieser K, et al. The clinical correlates of high-titer IgG anti-GM1 antibodies. Ann Neurol 1994;35: 234-237
28. Ogawa-Goto K, Funamoto N, Ohta Y, et al. Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina. J Neurochem 1992;59:1844-1849
29. Santoro M, Thomas FP, Fink ME, et al. IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, antiGM1 antibodies, and multifocal motor conduction block. Ann Neurol 1990;28:373-377
30. Willison HJ, Roberts M, O'Hanlon G, et al. Human monoclonal anti-GM1 ganglioside antibodies interfere with neuromuscular transmission. Ann Neurol 1994;36:289 (Abstract)
31. Nobile-Orazio E, Meucci N, Barbieri S, et al. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 1993;43:537-544
32. Van den Berg LH, Kerkhoff H, Oey PL, et al. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1995;59:248-252
33. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993;178:1771-1775
34. Oomes PG, Jacobs BC, Hazenberg MPH, et al. Anti-GM1 antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry. Ann Neurol 1995;38: 170-175
35. Yoshino H, Inuzuka T, Miyatake T. IgG antibody against GM1, GD1b and asialo-GM1 in chronic polyneuropathy following Mycoplasma pneumoniae infection. Eur Neurol 1992; 32:28-31
36. Fujimoto S, Amako K. Guillain-Barré syndrome and Campylobacter jejuni infection. Lancet 1990;35:1350 (Letter)
37. Kaldor J, Tong MQ, Dwyer B, et al. Guillain-Barré syndrome and Campylobacter jejunilcoli. Pathology 1992;24:125-126 (Letter)